Robert Paglia

Robert Paglia

Head of Market Access

Bob is the Head of Market Access at Servier Pharmaceuticals. He is responsible for the market access launch of a new biologic therapy for acute lymphoblastic leukemia, and for all aspects of market access including pricing and contracting, payer value demonstration, health economics and outcomes research, real world evidence strategy, payer engagement and government pricing. In his role, he collaborates on distribution and trade strategy, corporate development, federal and state healthcare policy, compliance and ethics

Bob has significant experience in U.S. and global pricing and market access and has held leadership positions at several life science consulting companies. Bob has held sales and marketing positions at Johnson & Johnson, Purdue Pharma, and Bristol Myers Squibb. He has experience in launching dozens of biopharmaceutical products in numerous therapeutic areas with specific expertise in Oncology, Hematology and Immunology. For over a decade, Bob was the Founder and President of Evolution Health Initiatives, an industry leading market access consulting and payer communications company. As an industry thought leader, Bob has published several peer-reviewed studies on pricing and market access and has made numerous presentations at congresses in the U.S., Europe, and Asia. 

Bob received his Bachelor of Science in Pharmacy from Rutgers University and a Master of Business Administration from Fairleigh Dickinson University.

To learn more about Bob connect with him on LinkedIn.

More from Servier

About Us

Servier Pharmaceuticals is a privately held pharmaceutical company focused on oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.

Learn More

Governance

Servier Pharmaceuticals is an independent, privately held United States company launched by Servier Group, a unique global organization, and is governed by a non-profit foundation.

Learn More

History

Servier has a 65-year history of helping provide innovative medicines to patients globally. In the United States, Servier intends to uphold and build upon that history. 

Learn More